# FDA 483 - Anika Therapeutics, Inc. - September 21, 2017

Source: https://www.globalkeysolutions.net/records/483/anika-therapeutics-inc/0c3395ae-f12a-40e0-941a-4b06cab3e0e6

> FDA 483 for Anika Therapeutics, Inc. on September 21, 2017. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Anika Therapeutics, Inc.
- Inspection Date: 2017-09-21
- Product Type: drugs
- Office Name: FDA District Office — Stoneham, Massachusetts

## Related Documents

- [483 - 2023-08-09](https://www.globalkeysolutions.net/records/483/anika-therapeutics-inc/07f93da9-af58-4dab-81db-f0d649fbbf2f)
- [483 - 2023-08-09](https://www.globalkeysolutions.net/records/483/anika-therapeutics-inc/7c15501b-2ab6-4c44-8e98-de59206f7f51)
- [483 - 2026-01-22](https://www.globalkeysolutions.net/records/483/anika-therapeutics-inc/6ee0397c-b2e8-4c3d-b45d-dd3386d4b81d)

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/erik-w-koester/2bbab081-6783-40a1-83c1-b219bde22bd1)
- [Arizona Market President](https://www.globalkeysolutions.net/people/john-p-mistler/7b2d423d-46cc-48bd-aa5a-4ae794888060)

Company: https://www.globalkeysolutions.net/companies/anika-therapeutics-inc/3499e53d-9858-4f0d-b826-b4a4a05ac3e7

Office: https://www.globalkeysolutions.net/offices/fda-district-office-stoneham-massachusetts/1daceb4f-4057-46cf-af02-d4ccde44dcc7